Contact
searchSearch
HMP Global

Hepatology Topic Center

Featured Article

News
Food Deserts and Swamps Linked to Higher MASLD Mortality, Study Finds
09/18/2025
Jessica Garlewicz
Interventions aimed at improving food access may play a key role in mitigating liver disease burden in vulnerable communities.
Interventions aimed at improving food access may play a key role in mitigating liver disease burden in vulnerable communities.
Interventions aimed at improving...
09/18/2025
Gastroenterology
Research Highlights
Incidence of Hepatocellular Carcinoma in MASLD Patients Quantified in Large Meta-Analysis
09/15/2025
Rebecca Mashaw
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight...
09/15/2025
Gastroenterology
FDA Alert
Obeticholic Acid Withdrawn From US Market for PBC; FDA Puts Clinical Trials on Hold
09/15/2025
Rebecca Mashaw
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will...
09/15/2025
Gastroenterology
News
Hypertension Linked to Liver Disease Progression and Adverse Outcomes in MASLD
09/04/2025
Jessica Garlewicz
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective...
09/04/2025
Gastroenterology
FDA alert
FDA Alert
FDA Approves Semaglutide for MASH With Advanced Fibrosis
08/21/2025
Rebecca Mashaw
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option...
08/21/2025
Gastroenterology
Research Highlights
Nontargeted HCV Screening Yields More Diagnoses Than Targeted Approaches
08/12/2025
Rebecca Mashaw
But only small percentages of patients were linked to follow-up treatment after diagnosis, researchers found.
But only small percentages of patients were linked to follow-up treatment after diagnosis, researchers found.
But only small percentages of...
08/12/2025
Gastroenterology
News
New Tool Predicts Risk of HCC Among Patients With MASLD
07/24/2025
Rebecca Mashaw
The novel risk factor model offers a clinically valuable strategy for hepatocellular carcinoma risk stratification.
The novel risk factor model offers a clinically valuable strategy for hepatocellular carcinoma risk stratification.
The novel risk factor model...
07/24/2025
Gastroenterology
Quiz
Social Determinants of Health and MASLD/MASH
07/18/2025
Rebecca Mashaw
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several social determinants of health (SDOH) are associated with the prevalence of metabolic-associated steatotic liver disease. What has been identified as the most consistent associated SDOH?
Research has shown that several...
07/18/2025
Gastroenterology
Quiz
MASLD in 2050
07/18/2025
Rebecca Mashaw
The prevalence of metabolic-associated steatotic liver disease (MASLD) is increasing. What will it be in the future? Take our quiz to find out.
The prevalence of metabolic-associated steatotic liver disease (MASLD) is increasing. What will it be in the future? Take our quiz to find out.
The prevalence of...
07/18/2025
Gastroenterology
Quiz
Risk Factors and Disease Implications in MASLD
07/01/2025
Rebecca Mashaw
Do you know the five cardiometabolic risk factors used in diagnosing MASLD? Check out our quiz to test your knowledge!
Do you know the five cardiometabolic risk factors used in diagnosing MASLD? Check out our quiz to test your knowledge!
Do you know the five...
07/01/2025
Gastroenterology
Quiz
Diagnostic Criteria for MASLD
07/01/2025
Rebecca Mashaw
07/01/2025
Gastroenterology

Videos

Blanca Lizaolo-Mayo
Video
How I Treat NASH (MASH)
11/15/2024
Blanca Lizaolo-Mayo, MD
Dr Lizaolo-Mayo discusses factors to consider when diagnosing and treating patients without obesity or overweight who may have metabolic-associated steatohepatitis (MASH).
Dr Lizaolo-Mayo discusses factors to consider when diagnosing and treating patients without obesity or overweight who may have metabolic-associated steatohepatitis (MASH).
Dr Lizaolo-Mayo discusses...
11/15/2024
Gastroenterology
Video
Kayla Monks, MS, RD, on Nutrition for Patients With Liver Disease
06/14/2024
Kayla Monks, MS, RD
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses...
06/14/2024
Gastroenterology
Lauren Yang, MD, on Hepatitis B Research
Videos
Lauren Yang, MD, on Hepatitis B Research
12/01/2020
In this video, Lauren Yang, MD, from Beth Israel Deaconess Medical Center, discusses what learned at the recent American Association for the Study of Liver Diseases annual meeting about research into managing hepatitis B.
In this video, Lauren Yang, MD, from Beth Israel Deaconess Medical Center, discusses what learned at the recent American Association for the Study of Liver Diseases annual meeting about research into managing hepatitis B.
In this video, Lauren Yang, MD,...
12/01/2020
Gastroenterology
Alan Bonder
Conference Coverage
Alan Bonder, MD, on New Therapies for Pruritis in Liver Disease
08/26/2025
Alan Bonder, MD
Dr Bonder recaps news from the European Association for the Study of the Liver meeting on new therapies being investigated for the relief of pruritis in patients with primary biliary cholangitis.
Dr Bonder recaps news from the European Association for the Study of the Liver meeting on new therapies being investigated for the relief of pruritis in patients with primary biliary cholangitis.
Dr Bonder recaps news from the...
08/26/2025
Gastroenterology
Sid Barritt
Videos
How I Treat MASLD/MASH: A Sidney Barritt, MD
07/23/2025
Dr Barritt explains how he works with patients (MASH) to to encourage and implement lifestyle interventions that can ameliorate metabolic-associated steatotic liver disease (MASLD) and metabolic-associated steatohepatitis.
Dr Barritt explains how he works with patients (MASH) to to encourage and implement lifestyle interventions that can ameliorate metabolic-associated steatotic liver disease (MASLD) and metabolic-associated steatohepatitis.
Dr Barritt explains how he works...
07/23/2025
Gastroenterology
Alan Bonder
Videos
Alan Bonder, MD, on Updates in Autoimmune Liver Disease
07/10/2025
Alan Bonder, MD
Dr Bonder reviews presentations from the European Association for Liver Diseases meeting providing updates on treatments for autoimmune liver diseases.
Dr Bonder reviews presentations from the European Association for Liver Diseases meeting providing updates on treatments for autoimmune liver diseases.
Dr Bonder reviews presentations...
07/10/2025
Gastroenterology
Video
Expert Roundtable: Staging and Treating NASH and MASLD
02/20/2025
Alan Bonder, MD; Gordon Jiang, MD; Hirsh Trivedi, MD
In part 2 of this video roundtable on NASH and MASLD, Drs Alan Bonder, Gordon Jiang, and Hirsh Trivedi discuss the staging of these conditions and lifestyle changes that patients can make to improve outcomes.
In part 2 of this video roundtable on NASH and MASLD, Drs Alan Bonder, Gordon Jiang, and Hirsh Trivedi discuss the staging of these conditions and lifestyle changes that patients can make to improve outcomes.
In part 2 of this video...
02/20/2025
Gastroenterology
Video
Expert Roundtable: Identifying Patients at Risk of NASH and MASLD
01/23/2025
Alan Bonder, MD; Hirsh Trivedi, MD; Gordon Jiang, MD
Alan Bonder, MD, Hirsh Trivedi, MD, and Gordon Jiang, MD, discuss the importance of identifying features of metabolic syndrome when assessing patients for potential metabolic dysfunction-associated liver disease--and starting the process at...
Alan Bonder, MD, Hirsh Trivedi, MD, and Gordon Jiang, MD, discuss the importance of identifying features of metabolic syndrome when assessing patients for potential metabolic dysfunction-associated liver disease--and starting the process at...
Alan Bonder, MD, Hirsh Trivedi,...
01/23/2025
Gastroenterology
Amy Oxentenko
Video
Amy Oxentenko, MD, on Updates in Celiac Disease
01/02/2025
Amy Oxentenko, MD
Dr Oxentenko gives a look into the future for the treatment of celiac disease, including the potential of therapies to offer alternatives to the gluten-free diet.
Dr Oxentenko gives a look into the future for the treatment of celiac disease, including the potential of therapies to offer alternatives to the gluten-free diet.
Dr Oxentenko gives a look into...
01/02/2025
Gastroenterology
Aasma Shaukat
Conference Coverage
Aasma Shaukat, MD, on Guidelines and Options for Colorectal Cancer Screening
12/04/2024
Aasma Shaukat, MD
Dr Shaukat reviews new alternatives for noninvasive colon cancer screening, including 2 stool-based and 1 blood-based test. 
Dr Shaukat reviews new alternatives for noninvasive colon cancer screening, including 2 stool-based and 1 blood-based test. 
Dr Shaukat reviews new...
12/04/2024
Gastroenterology
Aasma Shaukat
Conference Coverage
Aasma Shaukat, MD, on Risk Stratification for CRC Screening
11/22/2024
Aasma Shaukat, MD
Dr Shaukat discusses risk stratification for colorectal cancer screening and surveillance for low- and high-risk patients. 
Dr Shaukat discusses risk stratification for colorectal cancer screening and surveillance for low- and high-risk patients. 
Dr Shaukat discusses risk...
11/22/2024
Gastroenterology
Blanca Lizaolo-Mayo
Video
How I Treat Lean MASH
11/21/2024
Blanca Lizaolo-Mayo, MD
Blanca Lizaolo-Mayo, MD, reviews the importance of considering metabolic risk factors even among patients without obesity or overweight to detect metabolic dysfunction-related steatohepatitis.
Blanca Lizaolo-Mayo, MD, reviews the importance of considering metabolic risk factors even among patients without obesity or overweight to detect metabolic dysfunction-related steatohepatitis.
Blanca Lizaolo-Mayo, MD, reviews...
11/21/2024
Gastroenterology
Hirsh Trivedi
Video
Hirsh Trivedi, MD, on How I Treat MASH
11/20/2024
Hirsh Trivedi, MD
Dr Hirsh Trivedi details how he approaches the diagnosis and management of metabolic-dysfunction associated fatty liver disease (MAFLD, formerly NAFLD) and metabolic associated steatohepatosis (MASH, formerly NASH.)
Dr Hirsh Trivedi details how he approaches the diagnosis and management of metabolic-dysfunction associated fatty liver disease (MAFLD, formerly NAFLD) and metabolic associated steatohepatosis (MASH, formerly NASH.)
Dr Hirsh Trivedi details how he...
11/20/2024
Gastroenterology

News

Research Highlights
Incidence of Hepatocellular Carcinoma in MASLD Patients Quantified in Large Meta-Analysis
09/15/2025
Rebecca Mashaw
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight...
09/15/2025
Gastroenterology
FDA Alert
Obeticholic Acid Withdrawn From US Market for PBC; FDA Puts Clinical Trials on Hold
09/15/2025
Rebecca Mashaw
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will...
09/15/2025
Gastroenterology
News
Hypertension Linked to Liver Disease Progression and Adverse Outcomes in MASLD
09/04/2025
Jessica Garlewicz
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective...
09/04/2025
Gastroenterology
FDA alert
FDA Alert
FDA Approves Semaglutide for MASH With Advanced Fibrosis
08/21/2025
Rebecca Mashaw
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option...
08/21/2025
Gastroenterology
News
New Tool Predicts Risk of HCC Among Patients With MASLD
07/24/2025
Rebecca Mashaw
The novel risk factor model offers a clinically valuable strategy for hepatocellular carcinoma risk stratification.
The novel risk factor model offers a clinically valuable strategy for hepatocellular carcinoma risk stratification.
The novel risk factor model...
07/24/2025
Gastroenterology
Research Highlights
MASLD-Related Mortality Rising in US, Projected to Continue Through 2040
06/24/2025
Jessica Garlewicz
These findings stress the importance of early MASLD identification, risk stratification, and preventive care, especially in older, rural, and racially diverse populations most affected by the disease burden.
These findings stress the importance of early MASLD identification, risk stratification, and preventive care, especially in older, rural, and racially diverse populations most affected by the disease burden.
These findings stress the...
06/24/2025
Gastroenterology
Research Highlights
Phase 3 Trial Shows Semaglutide Improves Histologic Outcomes in MASH with Fibrosis
06/24/2025
Jessica Garlewicz
New research findings support semaglutide’s potential to address both hepatic histology and metabolic risk factors in patients with fibrosis, marking a promising step toward effective pharmacologic therapy in a disease with limited treatment...
New research findings support semaglutide’s potential to address both hepatic histology and metabolic risk factors in patients with fibrosis, marking a promising step toward effective pharmacologic therapy in a disease with limited treatment...
New research findings support...
06/24/2025
Gastroenterology
News
Bariatric Surgery Boosts Survival and Proves Cost-Effective for Patients With Obesity and Cirrhosis
04/28/2025
Riya Gandhi, MA
New study finds bariatric surgery improves survival and is cost-effective for patients with obesity and cirrhosis. See results on outcomes, ICER, and long-term health costs.
New study finds bariatric surgery improves survival and is cost-effective for patients with obesity and cirrhosis. See results on outcomes, ICER, and long-term health costs.
New study finds bariatric...
04/28/2025
Gastroenterology
News
Global Prevalence of Steatotic Liver Disease Exceeds One-Third of Population, Meta-Analysis Finds
04/15/2025
Jessica Garlewicz
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the...
04/15/2025
Gastroenterology
News
Diet Quality Emerges as Key Social Determinant in MASLD Severity and Prevalence
04/03/2025
Jessica Garlewicz
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from...
04/03/2025
Gastroenterology
Research Highlights
Incidence of Hepatocellular Carcinoma in MASLD Patients Quantified in Large Meta-Analysis
09/15/2025
Rebecca Mashaw
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight...
09/15/2025
Gastroenterology
FDA Alert
Obeticholic Acid Withdrawn From US Market for PBC; FDA Puts Clinical Trials on Hold
09/15/2025
Rebecca Mashaw
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will...
09/15/2025
Gastroenterology
Research Highlights
Analysis Challenges NordICC Trial Conclusions on CRC Screening and Mortality
09/05/2025
Rebecca Mashaw
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the...
09/05/2025
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
09/05/2025
Rebecca Mashaw
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
09/05/2025
Gastroenterology
Research Highlights
Fatty Pancreas Disease Linked to Elevated Risk of Pancreatic Cancer
09/04/2025
Jessica Garlewicz
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians...
09/04/2025
Gastroenterology
News
Hypertension Linked to Liver Disease Progression and Adverse Outcomes in MASLD
09/04/2025
Jessica Garlewicz
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective...
09/04/2025
Gastroenterology
News
GLP-1 Receptor Agonists Linked to Lower Risk of Peptic Ulcer Disease in Patients with T2DM
09/04/2025
Jessica Garlewicz
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional...
09/04/2025
Gastroenterology
FDA alert
FDA Alert
FDA Approves Semaglutide for MASH With Advanced Fibrosis
08/21/2025
Rebecca Mashaw
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option...
08/21/2025
Gastroenterology
News
Racial Disparities Persist in Colorectal Cancer Outcomes
08/12/2025
Rebecca Mashaw
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in...
08/12/2025
Gastroenterology
News
Over 20 Years of Colorectal Cancer Disparities Reveal Racial and Regional Gaps in US Mortality
08/08/2025
Riya Gandhi, MA
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in...
08/08/2025
Gastroenterology

Sign up for our e-Newsletters

Gastroenterology Newsletter

News

Research Highlights
Incidence of Hepatocellular Carcinoma in MASLD Patients Quantified in Large Meta-Analysis
09/15/2025
Rebecca Mashaw
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight...
09/15/2025
Gastroenterology
FDA Alert
Obeticholic Acid Withdrawn From US Market for PBC; FDA Puts Clinical Trials on Hold
09/15/2025
Rebecca Mashaw
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will...
09/15/2025
Gastroenterology
News
Hypertension Linked to Liver Disease Progression and Adverse Outcomes in MASLD
09/04/2025
Jessica Garlewicz
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective...
09/04/2025
Gastroenterology
FDA alert
FDA Alert
FDA Approves Semaglutide for MASH With Advanced Fibrosis
08/21/2025
Rebecca Mashaw
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option...
08/21/2025
Gastroenterology
News
New Tool Predicts Risk of HCC Among Patients With MASLD
07/24/2025
Rebecca Mashaw
The novel risk factor model offers a clinically valuable strategy for hepatocellular carcinoma risk stratification.
The novel risk factor model offers a clinically valuable strategy for hepatocellular carcinoma risk stratification.
The novel risk factor model...
07/24/2025
Gastroenterology
Research Highlights
MASLD-Related Mortality Rising in US, Projected to Continue Through 2040
06/24/2025
Jessica Garlewicz
These findings stress the importance of early MASLD identification, risk stratification, and preventive care, especially in older, rural, and racially diverse populations most affected by the disease burden.
These findings stress the importance of early MASLD identification, risk stratification, and preventive care, especially in older, rural, and racially diverse populations most affected by the disease burden.
These findings stress the...
06/24/2025
Gastroenterology
Research Highlights
Phase 3 Trial Shows Semaglutide Improves Histologic Outcomes in MASH with Fibrosis
06/24/2025
Jessica Garlewicz
New research findings support semaglutide’s potential to address both hepatic histology and metabolic risk factors in patients with fibrosis, marking a promising step toward effective pharmacologic therapy in a disease with limited treatment...
New research findings support semaglutide’s potential to address both hepatic histology and metabolic risk factors in patients with fibrosis, marking a promising step toward effective pharmacologic therapy in a disease with limited treatment...
New research findings support...
06/24/2025
Gastroenterology
News
Bariatric Surgery Boosts Survival and Proves Cost-Effective for Patients With Obesity and Cirrhosis
04/28/2025
Riya Gandhi, MA
New study finds bariatric surgery improves survival and is cost-effective for patients with obesity and cirrhosis. See results on outcomes, ICER, and long-term health costs.
New study finds bariatric surgery improves survival and is cost-effective for patients with obesity and cirrhosis. See results on outcomes, ICER, and long-term health costs.
New study finds bariatric...
04/28/2025
Gastroenterology
News
Global Prevalence of Steatotic Liver Disease Exceeds One-Third of Population, Meta-Analysis Finds
04/15/2025
Jessica Garlewicz
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the substantial burden of steatotic liver disease and highlight the importance of recognizing its distinct subtypes in clinical practice.
The findings underscore the...
04/15/2025
Gastroenterology
News
Diet Quality Emerges as Key Social Determinant in MASLD Severity and Prevalence
04/03/2025
Jessica Garlewicz
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from 18 studies and more than half a million subjects to better characterize how nonbiologic factors contribute to MASLD burden.
The study synthesizes data from...
04/03/2025
Gastroenterology
Research Highlights
Incidence of Hepatocellular Carcinoma in MASLD Patients Quantified in Large Meta-Analysis
09/15/2025
Rebecca Mashaw
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight markedly increased hepatocellular carcinoma risk among MASLD patients with advanced fibrosis.
Robust pooled data highlight...
09/15/2025
Gastroenterology
FDA Alert
Obeticholic Acid Withdrawn From US Market for PBC; FDA Puts Clinical Trials on Hold
09/15/2025
Rebecca Mashaw
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will voluntarily withdraw its obeticholic acid product, Ocaliva, from the US market for the treatment of primary biliary cholangitis.
Intercept Pharmaceuticals will...
09/15/2025
Gastroenterology
Research Highlights
Analysis Challenges NordICC Trial Conclusions on CRC Screening and Mortality
09/05/2025
Rebecca Mashaw
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the NordICC study may underestimate the mortality benefits of screening colonoscopy due to inadequate follow-up time.
The 10-year results from the...
09/05/2025
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
09/05/2025
Rebecca Mashaw
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
09/05/2025
Gastroenterology
Research Highlights
Fatty Pancreas Disease Linked to Elevated Risk of Pancreatic Cancer
09/04/2025
Jessica Garlewicz
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians is the importance of recognizing fatty pancreas disease as more than an incidental imaging finding.
The key takeaway for clinicians...
09/04/2025
Gastroenterology
News
Hypertension Linked to Liver Disease Progression and Adverse Outcomes in MASLD
09/04/2025
Jessica Garlewicz
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective cohorts, hypertension was consistently associated with worse liver-related and systemic outcomes.
Across three large prospective...
09/04/2025
Gastroenterology
News
GLP-1 Receptor Agonists Linked to Lower Risk of Peptic Ulcer Disease in Patients with T2DM
09/04/2025
Jessica Garlewicz
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional protection against gastrointestinal complications among patients with type 2 diabetes mellitus.
GLP-1 RAs may offer additional...
09/04/2025
Gastroenterology
FDA alert
FDA Alert
FDA Approves Semaglutide for MASH With Advanced Fibrosis
08/21/2025
Rebecca Mashaw
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option authorized by the agency for MASH with moderate to severe fibrosis addresses a growing public health challenge.
The first pharmacologic option...
08/21/2025
Gastroenterology
News
Racial Disparities Persist in Colorectal Cancer Outcomes
08/12/2025
Rebecca Mashaw
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in colorectal cancer screening and treatment, systemic inequities continue to drive higher incidence and mortality rates among Black Americans compared with White individuals, according to a recent review.
Despite significant advances in...
08/12/2025
Gastroenterology
News
Over 20 Years of Colorectal Cancer Disparities Reveal Racial and Regional Gaps in US Mortality
08/08/2025
Riya Gandhi, MA
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in colorectal cancer deaths, a 20-year study finds Black men and residents of Southern and Midwestern states continue to face disproportionately high mortality rates.
Despite national declines in...
08/08/2025
Gastroenterology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use